首页> 美国卫生研究院文献>other >Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis
【2h】

Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis

机译:在实验性多发性硬化症的动物模型中Drp1过度激活的抑制作用是保护性的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Multiple Sclerosis (MS), a leading neurological disorder of young adults, is characterized by the loss of oligodendrocytes (OLs), demyelination, inflammation and neuronal degeneration. Here we show that dynamin-related protein 1 (Drp1), a mitochondrial fission protein, is activated in primary OL cells exposed to TNF-α induced inflammation or oxidative stress, as well as in EAE-immunized and cuprizone toxicity-induced demyelinating mouse models. Inhibition of Drp1 hyper-activation by the selective inhibitor P110 abolishes Drp1 translocation to the mitochondria, reduces mitochondrial fragmentation and stems necrosis in primary OLs exposed to TNF-α and H2O2. Notably, in both types of mouse models, treatment with P110 significantly reduces the loss of mature OLs and demyelination, attenuates the number of active microglial cells and astrocytes, yet has no effect on the differentiation of oligodendrocyte precursor cells. Drp1 activation appears to be mediated through the RIPK1/RIPK3/MLKL/PGAM5 pathway during TNF-α-induced oligodendroglia necroptosis. Our results demonstrate a critical role of Drp1 hyper-activation in OL cell death and suggest that an inhibitor of Drp1 hyper-activation such as P110 is worth exploring for its ability to halt or slow the progression of MS.
机译:多发性硬化症(MS)是年轻人的主要神经系统疾病,其特征是少突胶质细胞(OL)丢失,脱髓鞘,炎症和神经元变性。在这里,我们显示了与线粒体裂变蛋白有关的动力蛋白1(Drp1)在暴露于TNF-α诱导的炎症或氧化应激的原代OL细胞中以及在EAE免疫和铜酮毒性诱导的脱髓鞘小鼠模型中被激活。选择性抑制剂P110对Drp1过度激活的抑制作用消除了Drp1向线粒体的易位,减少了线粒体的片段化,并在暴露于TNF-α和H2O2的原发性OL中引起了坏死。值得注意的是,在两种类型的小鼠模型中,用P110进行的治疗均显着减少了成熟OL的丢失和脱髓鞘,减弱了活性小胶质细胞和星形胶质细胞的数量,但对少突胶质前体细胞的分化没有影响。在TNF-α诱导的少突胶质细胞坏死病期间,Drp1激活似乎是通过RIPK1 / RIPK3 / MLKL / PGAM5途径介导的。我们的结果证明了Drp1过度激活在OL细胞死亡中的关键作用,并暗示了Drp1过度激活的抑制剂(例如P110)因其阻止或减缓MS进程的能力而值得探索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号